Home > Healthcare > Medical Devices > Medical Equipment > Biomedical Warming and Thawing Devices Market
Biomedical Warming and Thawing Devices Market size was valued at around USD 179 million in 2020 and is estimated to grow at a CAGR of 8.5% between 2021 and 2027. Increasing use of cryopreservation techniques for preservation of cells and tissues is expected to drive the market growth. Augmenting demand for automated biomedical warming and thawing devices is also contributing positively to the market expansion. Growing demand for pharmaceutical research is further poised to increase the adoption rate for biomedical warming and thawing devices, thereby fuelling the market progression during the forecast timeframe.
However, concerns associated with large batch size and stringent regulatory protocols related to use of cryopreserved and thawed biomedical products may render negative impact on the biomedical warming and thawing devices market share. Technical concerns such as low survival of the biomaterial sample, altered gene expression, loss of cellular characteristics, epigenetic changes, and shift in protein composition may limit the industry expansion. Moreover, regulatory guidelines for utilizing cryopreserved biologics in biomedical research have boosted the requirement for documented cell handling protocols. The storage and thawing of biomedical products are a complicated, sensitive and technology-oriented procedure.
Report Attribute | Details |
---|---|
Base Year: | 2020 |
Biomedical Warming and Thawing Devices Market Size in 2020: | USD 178.9 million |
Forecast Period: | 2021 to 2027 |
Forecast Period 2021 to 2027 CAGR: | 8.5% |
2027 Value Projection: | USD 308.1 million |
Historical Data for: | 2016 to 2020 |
No. of Pages: | 140 |
Tables, Charts & Figures: | 203 |
Segments covered: | Product, Sample, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Ideal conditions need to be maintained as per the guidelines for cryopreserved products to ensure maximum survival rate, viability, and functional importance. As a result, the storage and thawing of blood components and other products is monitored continuously by the U.S. FDA. The protocol differs as per country, as the mandate for defrosting and transportation of blood products differ with variable levels of technical assistance and legal framework. The regulatory frameworks majorly comprise of legislative instruments including legislation and regulations along with non-legislative instruments that includes policies, guidelines and supporting documents.